Pharmacogenomics of Acetaminophen in Pediatric Populations: a Moving Target
Acetaminophen (APAP) is widely used as an over-the-counter fever reducer and pain reliever. However, the current therapeutic use of APAP is not optimal. The inter-patient variability in both efficacy and toxicity limits the use of this drug. This is particularly an issue in pediatric populations, wh...
Main Author: | Wanqing eLiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00314/full |
Similar Items
-
Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock
by: C. Scorcella, et al.
Published: (2023-02-01) -
Statistical and computational pharmacogenomics /
by: 385533 Wu, Rongling, et al.
Published: (2009) -
Validation of ICD-9-CM codes for identification of acetaminophen-related emergency department visits in a large pediatric hospital
by: de Achaval Sofia, et al.
Published: (2013-02-01) -
Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01) -
Principles of pharmacogenetics and pharmacogenomics /
by: Altman, Russ B. 205766, et al.
Published: (2012)